In March 2025, the company introduced new options for any immediate-to-consumer supplying of its Wegovy weight loss drug. The company set up a brand new pharmacy, termed NovoCare, which might cost customers $499 per month for entry to the drug, lower than fifty percent the cost of the drug as a result of other pharmaceutical distribution networks.[